These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2800805)
1. [The natural cytotoxicity system in patients with multiple sclerosis: clinico-immunological parallels]. Cheknev SB; Latysheva OL; Demina TL; Sorokin AM; Gusev EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):16-9. PubMed ID: 2800805 [TBL] [Abstract][Full Text] [Related]
2. [Age-related characteristics of the natural cytotoxicity system in patients with multiple sclerosis and their possible relation to the pathogenesis of the disease]. Cheknev SB; Latysheva OL; Tunkel' OI Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):13-6. PubMed ID: 1647612 [TBL] [Abstract][Full Text] [Related]
3. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients]. Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743 [TBL] [Abstract][Full Text] [Related]
5. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor. Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232 [TBL] [Abstract][Full Text] [Related]
6. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus. Ewan PW; Barrett HM; Pusey CD J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577 [TBL] [Abstract][Full Text] [Related]
7. The regulatory role of natural killer cells in multiple sclerosis. Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129 [TBL] [Abstract][Full Text] [Related]
8. [Antibody-dependent and natural cellular cytotoxicity in patients with dilated cardiomyopathy]. Bakhov NI; Aleksandrova LZ; Osipov SG; Naumov VG; Rudnev VI Ter Arkh; 1986; 58(10):62-7. PubMed ID: 3798351 [TBL] [Abstract][Full Text] [Related]
9. Natural killer cell activity in patients with multiple sclerosis given alpha interferon. Rice GP; Casali P; Merigan TC; Oldstone MB Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954 [TBL] [Abstract][Full Text] [Related]
10. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit. Braakman E; van Tunen A; Meager A; Lucas CJ Clin Exp Immunol; 1986 Nov; 66(2):285-94. PubMed ID: 2949897 [TBL] [Abstract][Full Text] [Related]
11. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells. Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634 [TBL] [Abstract][Full Text] [Related]
12. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423 [TBL] [Abstract][Full Text] [Related]
13. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event. Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439 [TBL] [Abstract][Full Text] [Related]
15. [Regulation of the activity of human natural killer cells by autologous interferon]. Cheknev SB; Ershov FI; Pritsker AD; Latysheva OL Biull Eksp Biol Med; 1994 Sep; 118(9):281-4. PubMed ID: 7819561 [No Abstract] [Full Text] [Related]
16. Immunological studies on Crohn's disease. III. Defective natural killer activity. Okabe N; Fujita K; Yao T J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002 [TBL] [Abstract][Full Text] [Related]
17. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity. Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837 [TBL] [Abstract][Full Text] [Related]
18. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease. Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422 [TBL] [Abstract][Full Text] [Related]
19. Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease. Merrill J; Jondal M; Seeley J; Ullberg M; Sidén A Clin Exp Immunol; 1982 Feb; 47(2):419-30. PubMed ID: 6176377 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. Santoli D; Hall W; Kastrukoff L; Lisak RP; Perussia B; Trinchieri G; Koprowski H J Immunol; 1981 Apr; 126(4):1274-8. PubMed ID: 6162885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]